Projects and Grants per year
Personal profile
Education/Academic qualification
Post Doctoral Fellow, Henry Ford Hospital, Detroit, MI
2014
Residency, Henry Ford Hospital, Detroit, MI
2008
Bachelor of Medicine, Bachelor of Surgery, Kasturba Medical College
2001
-
A Phase 3, Randomized, Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy
Villano, PhD, J. (PI) & Thind, R. (CoI)
Orbus Therapeutics Incorporated
9/1/16 → 1/5/26
Project: Research project
-
15-LUN-100-HR: A Phase III, Open-label, Randomized Study of Atezolizumab (MPDL3280A, ANTI-PD-L1 Antibody) in Combination With Carboplatin or Cisplatin + Pemetrexed In Patients Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous
Arnold, S. (PI), Anthony, L. (CoI), Thind, R. (CoI), Villano, PhD, J. (CoI) & Hosein, P. (Former CoI)
4/29/16 → 10/20/20
Project: Research project
-
15-NEURO-06-NLG (NLG-2102) A Phase 1/2 Study of the Combination of Indoximod + Temozolomide for Adult Patients with Temozolomide-Refractory Primary Malignant Brain Tumors
Villano, PhD, J. (PI), St Clair, W. (CoI) & Thind, R. (CoI)
3/4/16 → 11/14/19
Project: Research project
-
15-28-HN-28-GT (GT-201): A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Effects of Intravenous GC4419 on the Incidence and Duration of Severe Oral Mucositis (OM) in Patients Receiving Post-Operative or Definitive Therapy
Kudrimoti, M. (PI), Arnold, S. (CoI), St Clair, W. (CoI) & Thind, R. (CoI)
Galera Therapeutics Incorporated
2/24/16 → 2/23/18
Project: Research project